Eribulin

• Target:

  ADC Cytotoxin|||Apoptosis|||Microtubule Associated

• Related Pathways:

  Apoptosis|||Antibody-drug Conjugate/ADC Related|||Cytoskeletal Signaling

• Purity:

  0.9996

• Bioactivity:

  Eribulin (B1939) is a nonpaclitaxel microtubule kinetic inhibitor with anticancer activity that inhibits polymerization of microtubule protein subunits by preventing lengthening and shortening of microtubules during cell division.Eribulin is used in the study of metastatic breast cancer and solid tumors.

• Smiles:

  [H][C@@]12CC (=C) [C@] ([H]) (CC[C@@]3 ([H]) C[C@@H] (C) C (=C) [C@@] ([H]) (C[C@]4 ([H]) O[C@H] (C[C@H] (O) CN) [C@H] (OC) [C@@]4 ([H]) CC (=O) C[C@@]4 ([H]) CC[C@]5 ([H]) O[C@@]6 ([H]) [C@@]7 ([H]) O[C@@]8 (C[C@@]7 ([H]) O[C@@]6 ([H]) [C@@] ([H]) (O8) [C@@]5 ([H]) O4) CC1) O3) O2

• Molecular Formula:

  C40H59NO11

• Molecular Weight:

  729.9

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  253128-41-5